Matrix Metalloproteinases in Experimental Autoimmune Encephalomyelitis

  • Bernd C. Kieseier
  • Hans-Peter Hartung
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 421)

Abstract

The matrix metalloproteinases (MMPs) belong to a large subgroup of Zn2+-dependent neutral endoproteinases, which includes the collagenases, gelatinases, and the stromelysins. The number of MMPs known is growing rapidly and they all share at least four common features [1]: (a) they all display proteolytic activity, (b) they are functionally active in the extracellular space, and on the eDNA level (c) protein sequences for the cysteine switch mechanism (PRCGxPD), which is important for their activation, and (d) protein sequences for the binding of catalytic zinc (HExGHxxGxxHS/T) can be found.

Keywords

Multiple Sclerosis Experimental Autoimmune Encephalomyelitis Proteolytic Activity Myelin Basic Protein Neuroinflammatory Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Woessner Jr JF. The family of matrix metalloproteinases. Ann NY Acad Sci 1994; 732: 11–21PubMedCrossRefGoogle Scholar
  2. 2.
    Takino T, Sato H, Yamamoto E, Seiki M. Cloning of a human gene potentially encoding a novel matrix metalloproteinase having a C-terminal transmembrane domain. Gene 1995; 155: 293–298PubMedCrossRefGoogle Scholar
  3. 3.
    Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe-Seyler 1995; 376: 345–355PubMedGoogle Scholar
  4. 4.
    Kleiner Jr DE, Stetler-Stevenson WG. Structural biochemistry and activation of matrix metalloproteases. Curr Opin Cell Biol 1993; 5: 891–897PubMedCrossRefGoogle Scholar
  5. 5.
    Murphy G, Willenbrock F, Crabbe T, O’Shea M, Ward R, Atkinson S. O’Connell J, Docherty A. Regulation of matrix metalloproteinase activity. Ann NY Acad Sci 1994; 732: 31–41PubMedCrossRefGoogle Scholar
  6. 6.
    Vassalli J-D, Pepper MS. Membrane proteases in focus. Nature 1994; 370: 14–15PubMedCrossRefGoogle Scholar
  7. 7.
    Krane SM. Clinical importance of matrix metalloproteinases and their inhibitors. Ann NY Acad Sci 1994; 732: 1–10PubMedCrossRefGoogle Scholar
  8. 8.
    Gearing AJH, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W. Wells G, Wood LM, Wooley K. Processing of tumor necrosis factor-a precursor by metalloproteinases. Nature 1994; 370: 555–557PubMedCrossRefGoogle Scholar
  9. 9.
    Mohler KM, Sleath PR, Fitzner JN, Cerretti DP, Alderson M, Kerwar SS, Torrance DS, Otten-Evans C, Greenstreet T, Weerawarna K, Kronheim SR, Petersen M. Gerhart M. Kozlosky CJ, March CJ, Black RA. Protection against lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing. Nature 1994; 370: 218–220PubMedCrossRefGoogle Scholar
  10. 10.
    Hartung HP. Pathogenesis of inflammatory demyelination: implications for therapy. Curr Opin Neurol 1995; 8: 191–199PubMedCrossRefGoogle Scholar
  11. 11.
    Schwanborg RH. Esperimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin immunol Immunopathol 1995; 77: 4–13CrossRefGoogle Scholar
  12. 12.
    Jung S, Toyka K, Hartung H-P. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2. Eur J Immunol 1995; 25: 1391–1398PubMedCrossRefGoogle Scholar
  13. 13.
    Lassmann H, Zimprich F, Rössler K, Vass K. Inflammation in the nervous system. Basic Mechanisms and immunological concepts. Rev Neurol (Paris) 1991; 147: 763–781Google Scholar
  14. 14.
    Cuzner ML, Davison AN, Rudge P. Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis. Ann Neurol 1978; 4: 337–344PubMedCrossRefGoogle Scholar
  15. 15.
    Gijbels K, Masure S, Carton H, Opdenakker G. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunoi 1992, 41: 29–34CrossRefGoogle Scholar
  16. 16.
    Rosenberg GA, Dencoff JE, Correa N, Reiners M, Ford CC. Effect asteroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology 1996; 46: 1626–1632PubMedCrossRefGoogle Scholar
  17. 17.
    Maeda A, Sobel RA. Matrix metalloproteinases in the normal human central nervous system. microglial nodules, and multiple sclerosis lesions. J Neuropathol Exp Neurol 1996; 55: 300–309PubMedCrossRefGoogle Scholar
  18. 18.
    Nielsen BS, Timshel S, Kjeldsen L. Sehested M. Pyke C, Borregaard N, Dano K. 92kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer 1996; 65: 57–62PubMedCrossRefGoogle Scholar
  19. 19.
    Welgus HG, Campbell EJ, Cury JD, Eisen AZ, Senior RM, Wilhelm SM, Goldberg Gl. Neutral metalloproteinases produced by human mononuclear phagocytes. J Clin invest 1990; 86: 1496–1502PubMedCrossRefGoogle Scholar
  20. 20.
    Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL. T cell gelatinases mediate basement membrane transmigration in vitro. J immunol 1995; 154: 4379–4389PubMedGoogle Scholar
  21. 21.
    Rosenberg GA, Dencoff JE, McGuire PG, Liotta LA, Stetler-Stevenson WA. Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain. Lab Invest 1994; 71: 417–422PubMedGoogle Scholar
  22. 22.
    Gijbels K, Galardy RE, Steinman L. Reversal of experimental autoimmune encephalomyelitis with a bydroxamate inhibitor of matrix metalloproteinases. J Clin Invest 1994; 94: 2177–2182PubMedCrossRefGoogle Scholar
  23. 23.
    Gijbels K, Proost P, Carton H, Billiau A, Opdenakker G. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J Neurosci Res 1993; 36: 432–440PubMedCrossRefGoogle Scholar
  24. 24.
    Chandler S, Coates R, Gearing A, Lury J, Wells G, Bone E. Matrix metalloproteinases degrade myelin basic protein. Neurosci Lett 1995; 201: 223–226PubMedCrossRefGoogle Scholar
  25. 25.
    Wells GMA, Catlin G, Cossins JA, Mangan M, Ward GA, Miller KM, Clements JM. Quantitation of matrix metalloproteinases in cultured rat astrocytes using the polymerase chain reaction with a multi-competitor cDNA standard. Glia 1996;in pressGoogle Scholar
  26. 26.
    Henriet P, Rousseau GG, Eeckhout Y. Cloning and sequencing of mouse collagenase cDNA. FEBS Lett 1992; 310: 175–178PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Bernd C. Kieseier
    • 1
  • Hans-Peter Hartung
    • 1
  1. 1.Department of Neurology Neuroimmunology Branch and Clinical Research Group for Multiple SclerosisJulius-Maximilians-UniversitätWürzburgGermany

Personalised recommendations